Your browser is no longer supported. Please, upgrade your browser.
PDLI PDL BioPharma, Inc. daily Stock Chart
PDLI [NASD]
PDL BioPharma, Inc.
Index- P/E- EPS (ttm)-0.79 Insider Own2.00% Shs Outstand122.90M Perf Week-0.61%
Market Cap378.18M Forward P/E18.69 EPS next Y0.18 Insider Trans0.00% Shs Float112.21M Perf Month16.89%
Income-93.50M PEG- EPS next Q0.10 Inst Own80.70% Short Float5.74% Perf Quarter15.86%
Sales54.10M P/S6.99 EPS this Y-25.60% Inst Trans-6.93% Short Ratio3.94 Perf Half Y30.87%
Book/sh4.50 P/B0.73 EPS next Y42.90% ROA- Target Price- Perf Year33.53%
Cash/sh1.09 P/C3.01 EPS next 5Y14.00% ROE- 52W Range1.71 - 3.41 Perf YTD21.39%
Dividend- P/FCF- EPS past 5Y-18.30% ROI-17.00% 52W High-4.11% Beta0.91
Dividend %- Quick Ratio13.00 Sales past 5Y-37.70% Gross Margin2.50% 52W Low91.22% ATR0.15
Employees75 Current Ratio13.20 Sales Q/Q-10.40% Oper. Margin- RSI (14)70.31 Volatility3.62% 5.59%
OptionableYes Debt/Eq0.02 EPS Q/Q-293.30% Profit Margin- Rel Volume0.51 Prev Close3.28
ShortableYes LT Debt/Eq0.02 EarningsMay 07 AMC Payout- Avg Volume1.64M Price3.27
Recom- SMA206.66% SMA5022.38% SMA20031.44% Volume838,659 Change-0.30%
Dec-22-16Resumed Piper Jaffray Overweight
Feb-23-16Reiterated RBC Capital Mkts Sector Perform $5 → $4
Feb-02-16Reiterated RBC Capital Mkts Sector Perform $6 → $5
Nov-05-15Reiterated RBC Capital Mkts Sector Perform $7 → $6
Oct-16-15Reiterated RBC Capital Mkts Sector Perform $8 → $7
Jan-20-11Upgrade RBC Capital Mkts Sector Perform → Outperform $6 → $6
Sep-10-10Initiated RBC Capital Mkts Sector Perform $6
Mar-27-09Upgrade Lazard Capital Mkts Hold → Buy $8
Mar-03-09Reiterated Wedbush Morgan Buy $15 → $9
Mar-03-09Reiterated JMP Securities Mkt Outperform $16 → $9
Jan-05-09Upgrade JP Morgan Underweight → Neutral
Dec-10-08Reiterated Credit Suisse Neutral $11 → $12
Sep-11-08Downgrade JP Morgan Neutral → Underweight
Jun-13-08Downgrade Credit Suisse Outperform → Neutral
May-12-08Reiterated Lehman Brothers Equal-Weight $16 → $12
Apr-22-08Downgrade Wachovia Outperform → Mkt Perform
Apr-11-08Reiterated Credit Suisse Outperform $19 → $16
Mar-10-08Downgrade Susquehanna Financial Positive → Neutral
Mar-06-08Reiterated BMO Capital Markets Market Perform $18 → $14
Mar-05-08Downgrade Lehman Brothers Overweight → Equal-weight $21 → $13
May-27-20 06:48AM  Edited Transcript of PDLI earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-21-20 04:05PM  PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders PR Newswire
May-18-20 04:05PM  PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders PR Newswire
May-08-20 09:00AM  PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript Motley Fool
Apr-30-20 08:30AM  PDL BioPharma to Announce First Quarter 2020 Financial Results on May 7, 2020 PR Newswire
Apr-10-20 11:30AM  Why Is PDL BioPharma (PDLI) Up 4.6% Since Last Earnings Report? Zacks
Apr-08-20 10:17PM  Edited Transcript of PDLI earnings conference call or presentation 11-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Mar-22-20 09:21AM  Estimating The Fair Value Of PDL BioPharma, Inc. (NASDAQ:PDLI) Simply Wall St.
Mar-13-20 09:18PM  13D Filings Barrons.com +5.24%
Mar-12-20 12:16PM  PDL BioPharma (PDLI) Misses on Q4 Earnings, To Dissolve by Year-End Zacks -6.84%
Mar-11-20 04:05PM  PDL BioPharma Reports 2019 Fourth Quarter and Full Year Financial Results and Announces Plan to Dissolve the Company by Year-End 2020 PR Newswire
02:30PM  PDL BioPharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-09-20 04:05PM  PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer PR Newswire -8.41%
Mar-04-20 08:30AM  PDL BioPharma to Announce 2019 Fourth Quarter and Full Year Financial Results on March 11, 2020 PR Newswire
Feb-28-20 08:00AM  PDL BioPharma Enters into Cooperation Agreement with Engine Capital PR Newswire
Feb-25-20 08:30AM  PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference PR Newswire
Jan-29-20 11:11AM  Incyte's Phase III Atopic Dermatitis Study Meets Primary Goal Zacks
Jan-28-20 11:14AM  AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study Zacks
Jan-27-20 10:43AM  Lower prices take shine off Petra Diamonds revenue MarketWatch
Jan-23-20 09:34AM  Axsome (AXSM) Completes Patient Randomization in TRD Study Zacks
Jan-22-20 10:00AM  Evoke Pharma's NDA Resubmission for Gimoti Gets FDA Acceptance Zacks
Jan-09-20 04:09PM  Catabasis (CATB) Partners with UK-Based Charity for DMD Study Zacks
Dec-23-19 11:36AM  PDL BioPharma (NASDAQ:PDLI) Shareholders Have Enjoyed A 60% Share Price Gain Simply Wall St.
Dec-19-19 08:30AM  PDL BioPharma Announces Upcoming Changes to its Board of Directors PR Newswire
Dec-16-19 08:30AM  PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million PR Newswire
Dec-13-19 08:30AM  PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024 PR Newswire
Dec-10-19 07:48PM  Should You Buy PDL BioPharma Inc. (PDLI)? Insider Monkey
03:21PM  Edited Transcript of PDLI earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
03:10PM  SevenSaoi Capital Supportive of PDL BioPharma Announcement PR Newswire
Dec-09-19 08:00AM  PDL BioPharma Announces Completion of Strategic Review Process PR Newswire +21.86%
Dec-06-19 11:31AM  Why Is PDL BioPharma (PDLI) Up 5.3% Since Last Earnings Report? Zacks
Dec-03-19 09:00AM  PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora® PR Newswire
Nov-14-19 08:56AM  PDL BioPharma Reaffirms Commitment To Shareholder Value Creation PR Newswire
07:00AM  Engine Capital Releases Presentation To Board Of PDL BioPharma PR Newswire
Nov-07-19 11:26AM  PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales Zacks
Nov-06-19 04:05PM  PDL BioPharma Reports 2019 Third Quarter Financial Results PR Newswire
Oct-31-19 02:13PM  PDL BioPharma Inc. (PDLI) Is Burning These Hedge Funds Insider Monkey
Oct-30-19 09:00AM  PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019 PR Newswire
Oct-25-19 07:12AM  The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug Benzinga
Oct-24-19 10:06PM  PDL BioPharma Responds to Letter from Engine Capital PR Newswire
Oct-23-19 07:00AM  Engine Capital Issues Open Letter to Board of PDL BioPharma PR Newswire +16.53%
Sep-26-19 09:00AM  PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-24-19 10:20AM  A Look At The Fair Value Of PDL BioPharma, Inc. (NASDAQ:PDLI) Simply Wall St.
Sep-12-19 10:20PM  PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024 PR Newswire
Sep-11-19 10:44PM  PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation PR Newswire
Sep-06-19 09:31AM  Why Is PDL BioPharma (PDLI) Down 20.1% Since Last Earnings Report? Zacks
Aug-28-19 07:27AM  Edited Transcript of PDLI earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-19 11:23AM  PDL Biopharma Inc (PDLI) Q2 2019 Earnings Call Transcript Motley Fool
10:17AM  PDL BioPharma (PDLI) Q2 Earnings Top Mark, Revenues Fall Y/Y Zacks
Aug-07-19 04:18PM  PDL BioPharma Reports 2019 Second Quarter Financial Results PR Newswire
07:34AM  The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Benzinga
Aug-05-19 04:10PM  Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Jul-31-19 09:00AM  PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019 PR Newswire
Jul-26-19 01:15PM  Here's Why PDL BioPharma (NASDAQ:PDLI) Might Be Better Off Without Debt Simply Wall St.
Jun-26-19 07:19AM  The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart Benzinga
Jun-25-19 04:05PM  PDL BioPharma Announces Departure of CFO PR Newswire
Jun-24-19 09:00AM  Natasha A. Hernday Elected to PDL BioPharma's Board of Directors PR Newswire
Jun-20-19 07:07PM  Were Hedge Funds Right About Flocking Into PDL BioPharma Inc. (PDLI) ? Insider Monkey
Jun-10-19 04:01PM  Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors PR Newswire
Jun-08-19 09:31AM  PDL BioPharma (PDLI) Down 9.7% Since Last Earnings Report: Can It Rebound? Zacks
May-30-19 11:02AM  PDL BioPharma's Royalties Help, Heavy Partner Reliance Hurts Zacks
May-28-19 09:00AM  PDL BioPharma to Participate in Jefferies 2019 Global Healthcare Conference PR Newswire
May-23-19 01:04PM  Introducing PDL BioPharma (NASDAQ:PDLI), The Stock That Slid 68% In The Last Five Years Simply Wall St.
May-22-19 01:33AM  Edited Transcript of PDLI earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-15-19 09:00AM  PDL BioPharma to Participate at UBS Global Healthcare Conference PR Newswire
May-12-19 06:27PM  Were Hedge Funds Right About Piling Into PDL BioPharma Inc. (PDLI)? Insider Monkey
May-10-19 10:51AM  PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y/Y Zacks
May-09-19 07:24PM  PDL Biopharma Inc (PDLI) Q1 2019 Earnings Call Transcript Motley Fool
05:37PM  PDL BioPharma: 1Q Earnings Snapshot Associated Press
04:05PM  PDL BioPharma Reports 2019 First Quarter Financial Results PR Newswire
May-08-19 10:38AM  Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More Zacks
May-07-19 06:00AM  Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
May-06-19 02:53PM  Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1 Zacks
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks
10:19AM  Agios (AGIO) Earnings and Revenues Surpass Estimates in Q1 Zacks
May-02-19 11:44AM  Acorda (ACOR) Earnings and Revenues Beat Estimates in Q1 Zacks
10:58AM  PDL BioPharma (PDLI) to Post Q1 Earnings: What's in Store? Zacks
09:00AM  PDL BioPharma to Announce First Quarter 2019 Financial Results on May 9, 2019 PR Newswire
May-01-19 11:46AM  Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates Zacks
Apr-26-19 02:04PM  BioMarin (BMRN) Shares Down Despite Q1 Earnings & Sales Beat Zacks
01:11PM  Seattle Genetics (SGEN) Q1 Loss Narrows, Revenues Top Mark Zacks
Apr-18-19 09:38AM  AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why Zacks
Apr-17-19 11:01AM  Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study Zacks -6.23%
10:46AM  Kamada to Begin Phase III Study for Inhaled AAT Product in 2H Zacks
Apr-16-19 04:05PM  PDL BioPharma to Hold Annual Meeting of Stockholders on June 20, 2019 PR Newswire
11:07AM  Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up Zacks
10:59AM  Fibrocell Out-licenses Skin Disease Gene Therapy, Stock Rises Zacks
Apr-15-19 10:50AM  Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study Zacks
Apr-13-19 09:30AM  PDL BioPharma (PDLI) Up 9.2% Since Last Earnings Report: Can It Continue? Zacks
Apr-11-19 10:25AM  PDL BioPharma Announces Equity Investment in Evofem Biosciences PR Newswire
10:19AM  Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma PR Newswire
10:04AM  Acorda to Gain From Inbrija Sales and Neurological Pipeline Zacks
Apr-10-19 10:00AM  PDL BioPharma (PDLI) is a Great Momentum Stock: Should You Buy? Zacks
Apr-09-19 10:30AM  Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457 Zacks
Apr-05-19 09:29AM  Puma Biotech Adds Two Cohorts to Nerlynx Label Expansion Study Zacks
Apr-02-19 03:03PM  4 Penny Stocks to Own for 2019 InvestorPlace
10:45AM  Puma Biotech Out-Licenses Nerlynx Rights in Europe, Stock Down Zacks
Mar-28-19 11:18AM  Blueprint Medicines Expediates Filings for Key Candidates Zacks
Mar-27-19 10:48AM  Agios (AGIO) Surges More Than 40% Year to Date: Here's Why Zacks
10:45AM  Agios Gains Breakthrough Therapy Status for Tibsovo Combo Zacks
PDL BioPharma, Inc. acquires, manages, and commercializes commercial stage pharmaceutical assets and late clinical stage pharmaceutical products in North America, Europe, Asia, and internationally. The company operates through Medical Devices, Strategic Positions, Pharmaceutical, and Income Generating Assets segments. The Medical Devices segment offers LENSAR laser systems for anterior capsulotomy, lens fragmentation, corneal and arcuate incisions to ophthalmic ambulatory surgical centers, specialty ophthalmic hospitals, and multi-specialty hospitals through a direct sales force. The Strategic Positions segment develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The Pharmaceutical segment manufactures, markets, and sells prescription medicine products for the treatment of hypertension to wholesalers under the Tekturna and Tekturna HCT names in the United States, as well as under the Rasilez and Rasilez HCT names internationally. The Income Generating Assets segment consists of notes and other long-term receivables; royalty rights and hybrid notes/royalty receivables; equity investments in healthcare companies; and royalties from issued patents covering the humanization of antibodies, including Avastin, Herceptin, Xolair, Perjeta, Kadcyla, and Tysabri. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PDL BIOPHARMA, INC.10% OwnerJun 10Buy4.506,666,66730,000,00213,333,334Jun 10 06:16 PM